The Efficacy of Biological Disease-modifying Antirheumatic Drugs on Sarcopenia in Patients with Rheumatoid Arthritis
Eriko Hasegawa, Satoshi Ito, Yoichi Kurosawa, Daisuke Kobayashi, Hiroshi Otani, Asami Abe, Kiyoshi Nakazono, Akira Murasawa, Ichiei Narita, Hajime Ishikawa
Abstract
Objective Sarcopenia is characterized by a loss of muscle mass and strength, which leads to frailty and mortality. Rheumatoid arthritis (RA) is considered to be a cause of sarcopenia. The present study assessed the effectiveness of biological disease-modifying antirheumatic drugs (bDMARDs) on sarcopenia.
Topics & Concepts
SarcopeniaMedicineRheumatoid arthritisAntirheumatic drugsAntirheumatic AgentsBiological drugsDiseaseInternal medicineArthritisNutrition and Health in AgingBody Composition Measurement TechniquesCerebral Palsy and Movement Disorders